Bayer AG Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEVERKUSEN, Germany, Feb 28 (Reuters) - Germany's largest drugmaker Bayer lifted its estimate for potential sales of new drugs by billions of euros on Friday, softening the blow of a fall in fourth-quarter earnings.

Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) in the last three months of 2013 slipped to 1.77 billion euros, dampened by a weak Japanese yen and emerging-market currencies, the company said, missing the 1.91 billion euro average estimate in a Reuters poll.

Help employers find you! Check out all the jobs and post your resume.

Back to news